Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
Oncogene|August 15, 2022
Lewis glycosphingolipids as critical determinants of TRAIL sensitivity in cancer cellsTomoya Fukuoka, Kenta Moriwaki, Shinji Takamatsu, et al.
The American Journal of Gastroenterology|January 8, 2008
IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel diseaseShinichiro Shinzaki, Hideki Iijima, Takatoshi Nakagawa, et al.
Hepatology Communications|February 7, 2018
Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosisYoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, et al.
Inflammatory Bowel Diseases|January 14, 2012
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's diseaseTakahiro Inoue, Hideki Iijima, Michiko Tajiri, et al.
Inflammatory Bowel Diseases|January 5, 2013
Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's diseaseShinichiro Shinzaki, Eri Kuroki, Hideki Iijima, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 18, 2024
Generation and validation of antibody 42B1 recognizing galactose-deficient IgG for diagnosis of chronic inflammatory diseasesNaoki Morishima, Maki Iwaisako, Yoshihiro Kamada, et al.
World Journal of Gastroenterology|May 10, 2016
Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitisTomohiro Maekawa, Yoshihiro Kamada, Yusuke Ebisutani, et al.
Biochemical and Biophysical Research Communications|November 8, 2018
Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancerTomohiro Maekawa, Risako Fukaya, Shinji Takamatsu, et al.
Pageof 26